# Moderately Hypofractionated Radiotherapy for Prostate Cancer.

> **NCT03827616** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Tatarstan Cancer Center** · enrollment: 400 (actual)

## Conditions studied

- Prostatic Neoplasms
- Genital Neoplasms

## Interventions

- **RADIATION:** Hypofractionated IMRT using helical Tomotherapy.
- **RADIATION:** Hypofractionated IMRT using helical Tomotherapy.

## Key facts

- **NCT ID:** NCT03827616
- **Lead sponsor:** Tatarstan Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-01-25
- **Primary completion:** 2029-02-01
- **Final completion:** 2030-02-01
- **Target enrollment:** 400 (ACTUAL)
- **Last updated:** 2026-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03827616

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03827616, "Moderately Hypofractionated Radiotherapy for Prostate Cancer.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03827616. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*